ASTM E2474 Standard Practice for Pharmaceutical Process Design Utilizing Process Analytical Technology (Withdrawn 2020)

ASTM E2474 Introduction

ASTM E2474 encompasses aspects such as the usage of sensors, analyzers, and statistical tools in order to comprehend and monitor the progress of manufacturing processes in real-time. A growing emphasis is being placed on modernizing pharmaceutical manufacturing through Process Analytical Technology. This standard facilitated the use of PAT in process development, scale-up, better quality assurance, less variability, and regulatory compliance in terms of both FDA and ICH requirements. It remains a historical fact that its withdrawal does not undermine the significance of its contribution towards good pharmaceutical designs.

ASTM E2474 Test Method

ASTM E2474 Equipment and Sample Preparation

ASTM E2474 Results and Interpretation

The typical outcome of a PAT-based process design is real-time process signatures, trend charts, and control limits of critical variables. Variability measurement helps to reduce it and maximize the quality of the product since it is carried out continuously during the process. Multivariate analysis and control charts are vital in addition to the interpretation of varied statistics to detect deviations or drifts, which instigate the feedback mechanism to deliver stability in the processes.

ASTM E2474 Related Test Methods

The set of tools and processes to run PAT described in E2474 is complemented by ASTM E2500 on the specification, design, and verification of pharmaceutical equipment and systems.

ASTM E2474 Applications in Industry 

During its active life, it was found to be utilized in the pharmaceutical industry as part of Quality-by-Design efforts and during the development and scale-up of solid-dosage products and sterile products. It directed the implementation of PAT tools at continuous manufacturing for approval of real-time release testing (RTRT) and lifecycle process validation.

ASTM E2474 Materials Commonly Tested

These also consisted of solid dosage forms (tablets and capsules) through which PAT tools were used to track the blending, granulation, and compression. It was also used in the development and production of lyophilized (freeze-dried) products, injectable solutions, and suspensions, where real-time monitoring provided consistency and sterility. Cell culture and fermentation products, which are biopharmaceutical intermediates, also contributed to the benefits of PAT-based control strategies.

ASTM E2474 Common Challenges and Troubleshooting

The implementation of this method faced challenges such as calibration of the sensors, adoption of PAT tools into the available equipment, and management of a large amount of data created. Poor interpretation of multiparameter data, as well as the insufficiency of cross-functional training, was an obstacle to adoption. 

ASTM E2474 Safety and Best Practices

Regular calibration and performance validation of instruments should be carried out to ensure the process does not have deviations. During the design and implementation processes, cross-functional documentation on the quality, engineering, and production functions shall be kept, facilitating traceability and accountability. All analytical methods and models should adopt a lifecycle approach, where monitoring, revalidation, and updating are continuously coupled as processes change.

Importance of ASTM E2474 Test Method

Although it was rescinded, this method has been an important part of the history of how pharmaceutical companies cogitated modern manufacturing. It helped move the mode of production using observation and empirical processes to a science-based mode of production. Inspiring the incorporation of real-time analytics, it contributed to an improvement in process knowledge, minimized out-of-specification cases, and promoted avenues for accommodating changing regulatory requirements. The FDA guidance documents and ICH Q8-Q10 principles describe the legacy of the organization.

By content81c70d6e36